Yang SJ, Hwang HK, Kang CM, Lee WJ. Preoperative defining system for pancreatic head cancer considering surgical resection. World J Gastroenterol 2016; 22(26): 6076-6082 [PMID: 27468199 DOI: 10.3748/wjg.v22.i26.6076]
Corresponding Author of This Article
Chang Moo Kang, MD, PhD, Department of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, South Korea. cmkang@yuhs.ac
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 14, 2016; 22(26): 6076-6082 Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6076
Table 1 Important abbreviations used in the new preoperative defining system for pancreatic cancer
Symbol
Description
Comments
Resectability
R
Resectable
BR
Borderline resectable
LA
Locally advanced
Location
H
Pancreatic head
Hu: uncinate process,
Hn: neck portion
Vascular structure
CA
Celiac axis
CHA
Common hepatic artery
GDA
Gastroduodenal artery
OGA: origin of gastroduodenal artery
aRHA
Aberrant right hepatic artery
Rt/Lt
Right/left
SMA
Superior mesenteric artery
SMV
Superior mesenteric vein
SMV-SV-PV
Superior mesenteric vein-splenic vein-portal vein
Table 2 Univariate analysis to predict combined venous vascular resection in treating pancreatic head cancer
Combined venous vascular resection
P value
No
Yes
Resectability
R
54
21
BR
17
17
LA
2
2
0.054
Radiologic tumor size (cm)
2.3 ± 0.7
2.6 ± 0.8
0.044
Tumor location
Head
49
24
Uncinate
22
13
Including neck
2
3
0.485
Radiologic vascular component
No
52
21
Yes
21
19
0.002
Initial preoperative serum CA19-9
846.7 ± 2193.9
805.3 ± 1761.9
0.919
Initial serum total bilirubin
4.3 ± 5.0
4.9 ± 4.6
0.528
Table 3 Univariate analysis to predict neoadjuvant treatment for pancreatic head cancer
Neoadjuvant treatment
P value
No
Yes
Resectability
R
52
23
BR
10
24
LA
1
3
< 0.001
Radiologic tumor size (cm)
2.1 ± 5.7
2.7 ± 0.9
< 0.001
Tumor location
Head
46
27
Uncinate
15
20
Including neck
2
3
0.049
Radiologic vascular component
No
52
21
Yes
11
29
< 0.001
Initial preoperative serum CA19-9
600.8 ± 1640.6
1109.0 ± 2437.1
0.189
Initial serum total bilirubin
3.9 ± 4.9
5.5 ± 4.9
0.087
Table 4 Oncologic impact of clinical variables used in the new preoperative defining system
Clinical variables
Exp(B)
95%CI
P value
Resectability
0.019
BR
0.222
0.073-0.676
0.008
LA
0.557
0.105-2.955
0.492
Radiologic tumor size (cm) ≥ 2.4
1.696
0.993-2.897
0.053
Tumor location
0.007
Hu
0.952
0.557-1.629
0.858
Hn
9.461
2.634-33.976
0.001
Vascular relationship with
0.064
Venous system
2.788
0.952-8.165
0.061
Arterial system
6.208
1.562-24.669
0.010
Both
2.200
0.484-10.006
0.307
CA19-9 ≥ 825
1.709
0.777-3.761
0.183
Total bilirubin ≥ 4.6
0.588
0.339-1.022
0.060
Adjusted CA19-9 ≥ 50
1.972
1.118-3.480
0.019
Citation: Yang SJ, Hwang HK, Kang CM, Lee WJ. Preoperative defining system for pancreatic head cancer considering surgical resection. World J Gastroenterol 2016; 22(26): 6076-6082